// App-Quantinova.ai

T4208 2016 AHA : Stimulation of Soluble Guanylate Cyclase Activity With Riociguat Promotes Angiogenesis and Improves Neovascularization After Hindlimb Ischemia

Researchers

Presenter

  • Sylvie Dussault

Principal Investigators

  • Michel Desjarlais

  • Raphael Mathieu

  • Alain Rivard

  • CRCHUM

Medical Centers

  • Montreal, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Coronary Artery Disease

Biomarkers

  • Mitogen-activated protein kinase 3

  • Cluster of Differentiation 31

Drug/Treatment

  • Riociguat

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved